Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Single Agent Ofatumumab in Relapsed / Refractory Mantle Cell Lymphoma
2009-017675-16Phase 2Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Aug 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ofatumumab in mantle cell lymphoma (MCL), sponsored by University Hospitals Plymouth. Primary endpoint: Disease progression. Started Aug 2010; status: completed.
02
Drugs
ofatumumab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2009-017675-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017675-16.